SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Global Biomarkers Markets Report 2014-2018: Cancer, Cardiac, Blood, Endocrine & Infectious Disease and Neurological Disease Markers

[August 21, 2014]

Research and Markets: Global Biomarkers Markets Report 2014-2018: Cancer, Cardiac, Blood, Endocrine & Infectious Disease and Neurological Disease Markers

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/9gfcfm/the_global_market) has announced the addition of the "The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Blood Markers, Endocrine Markers, Infectious Disease and Neurological Disease Markers)" report to their offering.

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, reimbursement specialists, research scientists, business development managers and marketing managers.

All market data are based on factory sales to the end user and not retail pricing or reimbursement payments. Market data pertains to the world market at the manufacturers' level. The base year for data was 2013. Historical data was provided for the ears 2008 through 2012, with forecast data provided for 2014 through 2018. Compound annual growth rates (CAGRs) are provided for the 2008-2013 and 2013-2018 periods for each segment covered.


Basic competitor summaries are included in each segment. The forecasted market analysis for 2014-2018 was largely based on demographic trends, new developments, biomarker development, company performance trends, merger and acquisitions, and global expansion.

Key Topics Covered:

Chapter One: Executive Summary

Chapter Two: Introduction To The Medical Biomarkers Industry

Chapter Three: Industry Trends

Chapter Four: Biomarkers In Cancer

Chapter Five: Biomarkers In Cardiovascular Disease And Blood Disorders

Chapter Six: Biomarkers In Endocrine And Immune Disorders

Chapter Seven: Biomarkers In Infectious Disease

Chapter Eight: Biomarkers In Nervous System Disorders

Chapter Nine: Market Summary

Chapter Ten: Company Profiles

  • 20/20 GeneSystems, Inc.
  • Abbott Laboratories
  • Affymetrix
  • Agendia, Inc. USA
  • Alere, Inc
  • Asuragen, Inc.
  • Beckman Coulter, Inc
  • Becton, Dickinson
  • BioReference Laboratories, Inc
  • Biocartis S.A.
  • Biodesix, Inc.
  • CARDIODX, INC
  • CELERA ALAMEDA
  • Clarient, Inc
  • DiaGenic ASA
  • Genomic Health, Inc.
  • Genoptix Medical Laboratory
  • Illumina, Inc.
  • Johnson & Johnson
  • Life Technologies Corporation
  • Memory Dx
  • Myriad Genetics, Inc.
  • Nanostring Technologies, Inc.
  • OPKO Health, Inc.
  • Qiagen N.V.
  • SIEMENS HEALTHCARE
  • Thermo Fisher Scientific
  • bioMerieux SA
  • biotheranostics, Inc.
  • deCODE Genetics, Inc.

For more information visit http://www.researchandmarkets.com/research/9gfcfm/the_global_market


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy